Cardiovascular biomarkers: A risky business Maral OuzounianDouglas S. LeePeter P. Liu Invited Commentary 11 July 2007 Pages: 177 - 179
Prehypertension: Progression to hypertension and management considerations Stephen D. Persell OriginalPaper 11 July 2007 Pages: 188 - 197
Do pleiotropic effects of antihypertensive medications exist or is it all about the blood pressure? Domenic A. Sica OriginalPaper 11 July 2007 Pages: 198 - 203
The J-curve relationship of treated diastolic blood pressure to mortality risk: Is it real? Is it clinically meaningful? William B. KannelRamachandran S. Vasan OriginalPaper 11 July 2007 Pages: 204 - 208
Ambulatory blood pressure monitoring in patients with diabetes mellitus: Current evidence and future trends Walter Palmas OriginalPaper 11 July 2007 Pages: 209 - 215
Does physical activity reduce the risk of cardiovascular disease in overweight and obese individuals? Glenn A. Gaesser OriginalPaper 11 July 2007 Pages: 221 - 227
The role of physical activity and fitness in the prevention and treatment of metabolic syndrome Peter T. KatzmarzykKatya M. Herman OriginalPaper 11 July 2007 Pages: 228 - 236
Physical activity interventions in clinical settings Rebecca A. MeriwetherSara WilcoxDeborah Parra-Medina OriginalPaper 11 July 2007 Pages: 237 - 246
What should the clinician tell patients with mild hypertension about physical activity? Véronique A. CornelissenRobert H. Fagard OriginalPaper 11 July 2007 Pages: 247 - 253
Exercise, visceral adipose tissue, and metabolic risk Jennifer L. KukPeter M. JaniszewskiRobert Ross OriginalPaper 11 July 2007 Pages: 254 - 264
Physical activity and reducing the risk of cardiovascular morbidity and mortality in older men and women: Lessons learned in 2006 Ian Janssen OriginalPaper 11 July 2007 Pages: 265 - 269
